Harmony Biosciences Holdings Inc Sustainability Reports
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company that focuses on developing and commercializing therapies for patients with rare neurological diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300JLJ5VQU2CN6016
FIGI: BBG00WBPG548
3 reports from 2022 to 2024
